Skip to main content
Log in

Unclear standard of care for pediatric high grade glioma patients

  • Letter to the Editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Finlay JL et al (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen Childrens Cancer Group. J Clin Oncol 13(1):112–123

    PubMed  CAS  Google Scholar 

  2. Cohen KJ et al (2011) Temozolomide in the treatment of high-grade gliomas in children: a report from the Children’s Oncology Group. Neuro Oncol 13(3):317–323

    Article  PubMed  CAS  Google Scholar 

  3. Sposto R et al (1989) The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 7(2):165–177

    Article  PubMed  CAS  Google Scholar 

  4. Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

  The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jason Fangusaro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fangusaro, J., Warren, K.E. Unclear standard of care for pediatric high grade glioma patients. J Neurooncol 113, 341–342 (2013). https://doi.org/10.1007/s11060-013-1104-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-013-1104-8

Keywords

Navigation